MedPath

Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation

Not Applicable
Conditions
Arsenic and/or Arsenic Compound Adverse Reaction
Registration Number
NCT05656664
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - =18 years of age<br><br> - Resident of the superfund site<br><br> - Clinically stable with no significant changes in general health status in the past 4<br> weeks prior to screening as assessed by the investigator<br><br> - Provide written informed consent<br><br>Exclusion Criteria:<br><br> - Pregnancy<br><br> - Ongoing folic acid nutritional supplementation<br><br> - Methotrexate use<br><br> - Megaloblastic anemia<br><br> - Alcoholic liver disease<br><br> - Malabsorptive syndromes - celiac disease, inflammatory bowel disease

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of urine and blood arsenic metabolites
Secondary Outcome Measures
NameTimeMethod
Respiratory Symptom Questionnaire;Pooled Cohort Probability Score
© Copyright 2025. All Rights Reserved by MedPath